ASH 2020 Conference Review - focus on Thrombosis & Haemophilia

In this review:

Impact of haemophilia A on daily life
Severe haemophilia A patients commencing emicizumab
Eptacog beta for joint bleeds
Etranacogene dezaparvovec for severe or moderate-severe haemophilia B
Fitusiran prophylaxis for haemophilia A or B
Soluble platelet agonists in heparin-induced thrombocytopenia
Haemostatic derangement in COVID-19 patients
Racial/ethnic disparities in CAT
DVT diagnosis with D-dimer adjusted to clinical probability
Australian and NZ Registry of anticoagulation in obese patients
Treatment pathways for newly diagnosed ITP
Tranexamic acid prophylaxis in haematologic malignancy
Rilzabrutinib for heavily pre-treated ITP
D-dimer improves risk prediction of VTE in MM
Circulating T follicular helper cells and B cells subsets in ITP

Please login below to download this issue (PDF)